Professional Documents
Culture Documents
Dinamicke Mutacije
Dinamicke Mutacije
CAMPUZANO, V., MONTERMINI, L., LUTZ, Y., COVA, L., HINDELANG, C., JIRALERSPONG S., TROTTIER, Y., KISH,
S.J., FAUCHEUX, B., TROUILLAS, P., ET AL. (1997) Frataxin is reduced in Friedreich ataxia
patients and is associated with mitochindrial membranes. Hum. Mol. Genet., 6, 17711780.
CUMMINGS, C.J. AND ZOGHBI, H.Y. (2000) Fourteen and counting: unraveling trinucleotide repeat
diseases. Hum. Mol. Genet., 9, 909-916.
HANCOCK, J.M. (1999) Microsatellites and other simple sequnences: genomic context and
mutational mechanisms. In Goldstein, D.B. and Schlotterer, C. (eds), Microsatellites:
Evolution and Applications, Oxford University Press, Oxsford, UK, pp.1-9.
HOWELER, C.J., BUSCH, H.F., GERAEDTS, J.P., NIERMEIJER, M.F., STAAL, A. (1989) Anticipation in
myotonic dystrophy: fact or fiction. Brain, 112, 779-797.
KANADIA, R.N., JOHNSTONE, K.A., MANKODI, A., LUNGU, C., THORNTON, C.A., ESSON, D., TIMMERS, A.M.,
HAUSWIRTH, W.W., SWANSON, M.S. (2003) A muscleblind knockout model for myotonic
dystrophy. Science, 302, 1978-1980.
LALIOTI, M.D., SCOTT, H.S., ANTONARAKIS, S.E. (1999) Altered spacing of promoter elements due
to the dodecamer repeat expansion contributes to reduced expression of the cystatin B
gene in EPM1. Hum. Mol. Genet., 8, 1791-1798.
LA SPADA, A.R., WILSON, E.M., LUBAHN, D.B., HARDING, A.E., FISCHBECK. K.H. (1991) Androgen
receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352,
77-79.
LIQUORI, C.L., RICKER, K., MOSELEY, M.L., JACOBSEN, J.F., KRESS, W., NAYLOR, S.L., DAY, J.W., RANUM,
L.P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
Science, 293, 864-867.
OBERLE, I., ROUSSEAU, F., HEITZ, D., KRETZ, C., DEVYS, D., HANAUER, A., BOUE, J., BERTHEAS, M.F.,
MANDEL, J.L. (1991) Instability of a 550-base pair DNA segment and abnormal
methylation in fragile X syndrome. Science, 252, 1097-1102.
PIERETTI, M., ZHANG, F.P., FU, Y.H., WARREN, S.T., OOSTRA, B.A., CASKEY, C.T., NELSON, D.L. (1991)
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66, 817-822.
RANUM, L.P. AND DAY, J.W. (2004) Myotonic dystrophy: RNA pathogenesis comes into focus. Am.
J. Hum.Genet., 74, 793-804.
RICHARDS, R.I. AND SUTHERLAND, G.R. (1992) Dynamic mutations: a new class of mutations
causing human disease. Cell, 70, 709-712.
RICHARDS, R.I. (2001) Dynamic mutations: a decade of unstable expanded repeats in human
genetic disease. Hum. Mol. Genet., 10, 2187-2194.
ROSS, C.A., POIRIER, M.A., WANKER, E.E., AMZEL, M. (2003) Polyglutamine fibrillogenesis: the
pathway unfolds. Proc. Natl. Acad. Sci USA, 100, 1-3.
ROSS, C.A., POIRIER, M.A. (2004) Protein aggregation and neurodegenerative disease. Nat Med.,
Suppl:S10-7.
TAUTZ, D. (1989) Hypervariability of simple sequences as a general source for polymorphic
DNA markers. Nucleic Acids Res., 17, 6463-6471.
VERKERK, A.J., PIERETTI, M., SUTCLIFFE, J.S., FU, Y.H., KUHL, D.P., PIZZUTI, A., REINER, O., RICHARDS, S.,
VICTORIA, M.F., ZHANG, F.P., ET AL. (1991) Identification of a gene (FMR-1) containing a
CGG repeat coincident with a breakpoint cluster region exhibiting length variation in
fragile X syndrome. Cell, 65,905-914.
WEBER, J.L. AND WONG, C. (1993) Mutation of human short tandem epeats. Hum. Mol. Genet., 2,
1123-1128.
WANG, J., PEGORARO, E., MENEGAZZO, E., GENNARELLI, M., HOOP, R.C., ANGELINI, C., HOFFMAN, E.P.
(1995) Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation.
Hum. Mol. Genet., 4, 599-606.
ZHANG, X., SMITH, D.L., MERIIN, A.B., ENGEMANN, S., RUSSEL, D.E., ROARK, M., WASHINGTON, S.L.,
MAXWELL, M.M., MARSH, L., THOMPSON, L.M., ET AL. (2005) A potent small molecule inhibits
polyglutamine aggregation in Huntington's disease neurons and suppresses
neurodegeneration in vivo. Proc. Natl. Acad. Sci USA, 102, 892-897.
Loku
s
Gen*
Protein
Tip
ponovk
a
Lokacij
au
genu
Normaln
i aleli
Bolesni
aleli
OMIM
ID**
Gen*
Lokus
Protein
Normalni
aleli
Bolesni
aleli
OMIM
ID**
HD
4p16
Hantingtin
6-35
36-121
143100